Trial Profile
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2019
Price :
$35
*
At a glance
- Drugs Vatiquinone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms EPIPD
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology
- 21 Apr 2016 Status changed from active, no longer recruiting to completed, according to the results presented at the 68th Annual Meeting of the American Academy of Neurology.
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology